Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page
- Check6 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants,' indicating the study is not enrolling; the history now shows a new revision tag (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

- Check13 days agoChange DetectedThe revision line on the history page was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new version of the page template or data.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry appears: v3.5.4 replaces the previous v3.5.3 in the page history, reflecting an update to the revision metadata.SummaryDifference0.0%

- Check56 days agoChange DetectedClinicalTrials.gov’s page revision indicator was updated from v3.5.0 to v3.5.3, reflecting a technical/UI release rather than a change to the study record itself.SummaryDifference0.0%

- Check92 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check107 days agoChange DetectedA new Revision: v3.4.3 entry was added and the previous Revision: v3.4.2 entry was removed from the history.SummaryDifference0.0%

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.